4.6 Article

The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels

期刊

CANCER MEDICINE
卷 11, 期 5, 页码 1357-1370

出版社

WILEY
DOI: 10.1002/cam4.4530

关键词

disability-adjusted life years; global burden of disease; incidence; liver cancer; mortality

类别

资金

  1. Hubei Chen Xiaoping Technology Development Fund [CXPJJH1190000--2019321, lryjj201904]
  2. Liuzhou Science and Technology Bureau [2018BJ10302]

向作者/读者索取更多资源

This study presents the burden of liver cancer at the global, regional, and national levels. Liver cancer remains a major public health issue worldwide, with a high number of mortalities and incident cases in 2019. Hepatitis B and Hepatitis C are the main causes of liver cancer mortality. China has the highest burden of liver cancer, both in terms of deaths and disease burden.
Background Liver cancer is one of the most common cancers worldwide. We aimed to report the burden of liver cancer at the global, regional, and national levels in 204 countries from 1990 to 2019, stratified by etiology, sex, age, and sociodemographic index (SDI). Methods Data of mortality, incidence, and disability-adjusted life years (DALYs) of liver cancer and its etiology were available from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2019. The trends in the liver cancer burden were assessed by the annual percentage change. All estimates are presented as numbers and age-standardized rates (ASRs) per 100,000 population, with uncertainty intervals (UIs). Results Globally, 484,577 (95% UI 444,091-525,798) mortalities, 534,364 (486,550-588,639) incident cases, and 12,528,422 (11,400,671-13,687,675) disability-adjusted life years (DALYs) due to liver cancer occurred in 2019. The ASRs were 5.95 (5.44-6.44), 6.51 (5.95-7.16), and 151.08 (137.53-164.8) per 100,000 population for the mortalities, incidences, and DALYs, respectively. From 1990 to 2019, the numbers increased, whereas the ASRs decreased. Hepatitis B and Hepatitis C are the major causes of liver cancer mortality. The liver cancer mortality in 2019 increased with age, peaking at 65-69 and 70-74 age group in males and females, respectively, and the number was higher in males than in females. Generally, there were nonlinear associations between the ASR and SDIs values at the regional and national levels. China had the highest numbers of mortalities, incident cases, and DALYs, whereas Mongolia has the highest ASR in 2019. Conclusion Liver cancer remains a major public health issue worldwide, but etiological and geographical variations exist. It is necessary to increase awareness of the population regarding liver cancer, its etiologies and the importance of early detection, and diagnosis and treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据